Jennifer L. Taubert - 14 Feb 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role: EVP, WW Chair, Pharmaceuticals
Signature: Raavi K. Deol, as attorney-in-fact for Jennifer L. Taubert
Issuer symbol: JNJ
Transactions as of: 14 Feb 2022
Net transactions value: -$200,932
Form type: 4
Filing time: 15 Feb 2022, 19:02:45 UTC
Next filing: 07 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JNJ	Common Stock	Options Exercise	$0	+3,297	+2.9%	$0.000000	118,423	14 Feb 2022	Direct	F1
transaction	JNJ	Common Stock	Tax liability	$200,932	-1,190	-1%	$168.85	117,233	14 Feb 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JNJ	Restricted Share Units	Options Exercise	$0	-3,297	-100%	$0.000000^*	0	14 Feb 2022	Common Stock	3,297		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
F2	Shares withheld for payment of taxes upon vesting of Restricted Share Units.